R. Gary Sibbald, BSc, MD, MEd, FRCPC(Med Derm), MACP, FAAD, MAPWCA, is Professor of Public Health and Medicine, University of Toronto, Ontario, Canada; Director, International Interprofessional Wound Care Course & Masters of Science in Community Health (Prevention & Wound Care), Dalla Lana School of Public Health, University of Toronto; Past President, World Union of Wound Healing Societies; Course Coordinator, International Interprofessional Wound Care Course at New York University Medical Center, and Clinical Editor, Advances in Skin & Wound Care, Philadelphia, Pennsylvania. Liza G. Ovington, PhD, FACCWS, is Director, Medical Operations, Global Surgery Group, Ethicon Inc, Somerville, New Jersey. Elizabeth A. Ayello, PhD, RN, ACNS-BC, CWON, ETN, MAPCWA, FAAN, is Faculty, Excelsior College of Nursing, Albany, New York; Senior Advisor, The John A. Hartford Institute for Geriatric Nursing, New York; President, Ayello, Harris & Associates, New York; Course Coordinator, International Interprofessional Wound Care Course at New York University Medical Center; and Clinical Editor, Advances in Skin & Wound Care, Philadelphia, Pennsylvania. Laurie Goodman, MHScN, BA, RN, IIWCC (Toronto), is an Advanced Practice Nurse and Wound Educator, Toronto Regional Wound Healing Clinics, Ontario, Canada. James A. Elliott, MMsc, BSc, is an independent researcher, Toronto, Canada. Dr Sibbald has disclosed that his employer, the University of Toronto, is the recipient of an unconditional educational grant from Hollister Inc, research grants from Healthpoint Biotherapeutics, Systagenix, and Exiton, and was the recipient of research grants from the Government of Ontario, 3M, BSN, CIDA, Coloplast, Covidien, Gaymar, KCI, Johnson & Johnson, Registered Nurses Association of Ontario, Mölnlycke, Hollister Limited, Valeant, Shire, Galderma, Leo, Stiefel, Abbott, and Mississauga Halton Community Care Access Center; he is a board member of 3M, BSN, Coloplast, Covidien, Gaymar, KCI, Systagenix, Möln
Adv Skin Wound Care. 2014 Mar;27(3 Suppl 1):1-6. doi: 10.1097/01.ASW.0000443269.63406.f9.
Wound bed preparation (WBP) is a paradigm for holistic patient care that includes treatment of the cause along with patient-centered concerns before optimizing the components of local wound care (debridement, infection/inflammation, moisture balance, and, when required, the edge effect). This review incorporates a methylene blue and gentian violet bound foam dressing for critical colonization and an ovine collagen extracellular matrix dressing for reduction of elevated levels of matrix metalloproteases into the WBP paradigm.
创面床准备（WBP）是一种整体患者护理模式，包括在优化局部伤口护理（清创、感染/炎症、水分平衡以及在需要时边缘效应）的组成部分之前，同时关注患者的关注点和病因。本综述将甲紫-亚甲蓝结合泡沫敷料用于临界定植和绵羊胶原蛋白细胞外基质敷料用于降低基质金属蛋白酶水平纳入 WBP 模式。
